Northern Trust’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$215K Buy
310,654
+69,074
+29% +$51K ﹤0.01% 3925
2025
Q4
$172K Buy
241,580
+2,091
+0.9% +$2.84K ﹤0.01% 4028
2025
Q3
$388K Buy
239,489
+110,044
+85% +$111K ﹤0.01% 3738
2025
Q2
$79.1K Sell
129,445
-315,595
-71% -$161K ﹤0.01% 4156
2025
Q1
$254K Sell
445,040
-27,439
-6% -$27.1K ﹤0.01% 3854
2024
Q4
$676K Buy
472,479
+27,632
+6% +$61.9K ﹤0.01% 3545
2024
Q3
$859K Buy
444,847
+50,843
+13% +$144K ﹤0.01% 3412
2024
Q2
$1.22M Sell
394,004
-3,657
-0.9% -$15.1K ﹤0.01% 3154
2024
Q1
$2.08M Buy
397,661
+7,979
+2% +$38.2K ﹤0.01% 2936
2023
Q4
$1.26M Sell
389,682
-39,551
-9% -$85.4K ﹤0.01% 3231
2023
Q3
$1.09M Buy
429,233
+11,625
+3% +$48.7K ﹤0.01% 3263
2023
Q2
$2.45M Buy
417,608
+69,664
+20% +$405K ﹤0.01% 2894
2023
Q1
$992K Buy
347,944
+124,832
+56% +$351K ﹤0.01% 3224
2022
Q4
$448K Sell
223,112
-7,707
-3% -$18.8K ﹤0.01% 3546
2022
Q3
$670K Buy
230,819
+8,704
+4% +$40.6K ﹤0.01% 3413
2022
Q2
$1.25M Sell
222,115
-9,344
-4% -$75.6K ﹤0.01% 3282
2022
Q1
$2.73M Buy
231,459
+91,586
+65% +$1.11M ﹤0.01% 2938
2021
Q4
$2.65M Buy
139,873
+16,583
+13% +$361K ﹤0.01% 3078
2021
Q3
$2.54M Buy
+123,290
New +$2.65M ﹤0.01% 3147

Other funds holding TNYA

Northern Trust's TNYA Position: Q1 2026 in Review

Northern Trust increased its Tenaya Therapeutics (TNYA) stake by 29% in Q1 2026, buying an estimated $51K and bringing the position to 310,654 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #3925.

Northern Trust first reported a position in TNYA in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.73M in Q1 2022. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Northern Trust held 310,654 shares of Tenaya Therapeutics worth $215K as of Q1 2026.
  • Northern Trust bought 69,074 Tenaya Therapeutics shares in Q1 2026, an estimated $51K.
  • Tenaya Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3925 holding.
  • Northern Trust first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Northern Trust's Tenaya Therapeutics position peaked at $2.73M in Q1 2022.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.